The table below shows AYTU BIOPHARMA, INC's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q4 2025
Q3 2025
Q1 2025
Q4 2024
Q3 2024
Revenue
$12.41M
$15.16M
$13.89M
$18.45M
$16.22M
$16.57M
Cost of revenue
$4.81M
$5.54M
$4.70M
$5.65M
$5.43M
$4.59M
Gross profit
$7.60M
$9.62M
$9.19M
$12.81M
$10.79M
$11.98M
R&D
$0.00
$0.00
$0.00
$162.00K
$522.00K
$426.00K
AYTU annual revenue (10-K history)
AYTU BIOPHARMA, INC reported annual revenue of $66.38M for fiscal year 2025. That is up 1.8% from $65.18M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $2.56M (FY 2016) to $66.38M. Figures come from the company's audited annual reports as filed with the SEC.